Nemera designs and manufactures drug delivery devices and combination products for pharmaceutical, biotechnology and generic customers. Founded in 2014 following Montagu's acquisition of Rexam's Healthcare and Retail Prescription divisions, the company operates production facilities in France, Germany, Poland, the United States and Brazil, serving 54 countries and selling over a billion devices annually.
The company specializes across five delivery routes: ophthalmic systems (preservative-free multidose eyedroppers), nasal, buccal and auricular components (pumps, valves and actuators for sprays), inhalation devices (pMDI and DPI inhalers for asthma and COPD), dermal and transdermal dispensers (airless and atmospheric), and parenteral devices (auto-injectors, pens, safety devices and implanters). Each product category reflects Nemera's focus on ergonomics and dosing engineering to support treatment adherence and clinical outcomes.
The company offers comprehensive device strategy services spanning early-stage development through commercialization and manufacturing at scale. Its headquarters are in Lyon, France.
